Genomic aberrations and survival in chronic lymphocytic leukemia - Wikidata - wikimedia - TriplyDB

Genomic aberrations and survival in chronic lymphocytic leukemia

Genomic aberrations and survival in chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q28141442

about

Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL)Detectable clonal mosaicism and its relationship to aging and cancer Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis Characterization of large structural genetic mosaicism in human autosome Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Alemtuzumab for patients with chronic lymphocytic leukaemia Alemtuzumab for chronic lymphocytic leukaemia Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia Purine Antagonists for Chronic Lymphocytic Leukaemia HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia 13q14 deletions in CLL involve cooperating tumor suppressors Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia Stem cell transplantation in chronic lymphocytic leukemia Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications Clinical significance of microRNAs in chronic and acute human leukemia Chronic lymphocytic leukemia: a clinical review including Korean cohorts Current concepts in diagnosis and treatment of chronic lymphocytic leukemia TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist Targeting ATM-deficient CLL through interference with DNA repair pathways Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution Nodal and leukemic small B-cell neoplasms Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia Clinical implications of the molecular genetics of chronic lymphocytic leukemia Ibrutinib (PCI-32765) in chronic lymphocytic leukemia Immunological aspects in chronic lymphocytic leukemia (CLL) development Aneuploidy in pluripotent stem cells and implications for cancerous transformation Hematopoietic stem cell allografting for chronic lymphocytic leukemia: a focus on reduced-intensity conditioning regimens

P2860

Q21562355-D9264F4D-6DA7-4C35-A3B4-D1BBD8C390AB Q23916196-9E7D01D5-2D8C-4A7D-9E52-9026D4C17ADB Q23917829-083C6CE9-9C96-4B6B-8EBE-3BA148B9C7A6 Q24169697-DCCA4FE2-7B36-4459-8878-DE3663911E9F Q24186840-DB679B42-92B3-4D04-A568-CB812808E0D4 Q24198941-902CD3E0-177E-4085-BA06-06D28BF15C87 Q24203027-30388E55-21C3-4A33-B4C7-3374CCF372B7 Q24203628-E7A5EDFF-1475-46F3-8CB6-5697AFFCFA14 Q24240922-84041B72-9FC0-46C2-B02A-0DC9346D42FD Q24241519-E8176485-2F18-4627-9411-FC86152EE3DC Q24245132-A40CC9A0-4E0B-43E6-A8ED-074901750F11 Q24311673-D29497E9-19C5-491C-8111-8085136BE1AB Q24539231-6CDC380C-DEED-4C42-9C43-1764FA7BCA0B Q24564008-E83DBDE8-C539-4BB5-A36B-56225314CB1A Q24598248-4EE9BA2D-626F-44EA-A86D-8778FDE1B95F Q24614789-3DC1B565-AE36-497C-B591-5DDD20BC4EE4 Q24616084-F325699F-9A3E-4CC3-9190-55FA3421A4E5 Q24617708-0BBE3E6F-364F-4038-948C-4C2CCB9D49A5 Q24618669-4D82E265-C701-49B8-AC7F-388AE45F0B87 Q24642439-FC303DB5-4DF6-4C56-B88A-E8A13E88F9E9 Q24642921-B19405C1-5626-4559-AEE9-62FB69DE17C1 Q24649526-1B5DD508-2903-4BC9-8FF4-8D479F66C426 Q24657747-E32546AE-0C25-4C72-BC3C-FAC852691232 Q24675006-C55BCED7-6E5D-4337-B24A-491C85FADEA0 Q24683729-6DC5CD8D-3F73-4F3D-A7AA-FB059EA9324F Q26749533-3515D069-33FC-4757-836F-E1F813B18C46 Q26752467-AABC1DC4-7DB4-4F41-A09D-9218F61C5BF1 Q26770471-6B15F6EC-3C67-4D8D-8E57-67E2D9106DA4 Q26773053-47CA03A1-3CEA-41F7-B968-B3F2E5E2B1E7 Q26775506-72E5A306-2501-43C3-9BF4-18CE362EC3CD Q26775986-FEB56B7D-82CE-4B03-A2D4-8F098D6ABD37 Q26822592-449525DF-CAA2-4B86-9DD1-2131EA26E8C8 Q26823586-B574897A-E36B-437F-9AF9-746DEE39953F Q26829315-D88652D5-0440-45AF-8608-E93F51141D40 Q26830323-355AD9AC-353D-461D-9A21-17AFC9CE1C83 Q26830955-03E68648-7D39-4DCE-AD8B-8EAD8E923BCE Q26852328-A1387A3B-C995-4FB5-B4C3-0EB589A46E84 Q26865940-FF5E7416-8F3B-4787-BE9A-284FDE7FDDCD Q27013982-C056D6D6-C203-433C-B8C3-25FD40F3ECF8 Q27021206-2BDFC2E7-1F20-4381-93E8-898E5ADA1B05

P2860

Genomic aberrations and survival in chronic lymphocytic leukemia

http://www.wikidata.org/entity/Q28141442

description

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2000

@ast

im Dezember 2000 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 28 December 2000)

@en

vedecký článok (publikovaný 2000/12/28)

@sk

vědecký článek publikovaný v roce 2000

@cs

wetenschappelijk artikel (gepubliceerd op 2000/12/28)

@nl

наукова стаття, опублікована в грудні 2000

@uk

مقالة علمية (نشرت في 28-12-2000)

@ar

name

Genomic aberrations and survival in chronic lymphocytic leukemia

@ast

Genomic aberrations and survival in chronic lymphocytic leukemia

@en

Genomic aberrations and survival in chronic lymphocytic leukemia

@nl

type

label

Genomic aberrations and survival in chronic lymphocytic leukemia

@ast

Genomic aberrations and survival in chronic lymphocytic leukemia

@en

Genomic aberrations and survival in chronic lymphocytic leukemia

@nl

prefLabel

Genomic aberrations and survival in chronic lymphocytic leukemia

@ast

Genomic aberrations and survival in chronic lymphocytic leukemia

@en

Genomic aberrations and survival in chronic lymphocytic leukemia

@nl

P1433

Q28141442-89457563-2E88-4FC9-BC2A-E10EE3487A29

P1476

Q28141442-7B84AA35-91D9-4B87-A9C3-F7CE3982EB0A

P2093

Q28141442-278FDE60-A527-4D3A-8FC3-B173833C952A

Q28141442-309D74CB-4F0F-4BD4-B60B-7B46FC16699E

Q28141442-55A1DF23-46F4-4A66-993C-24779EF4FC19

Q28141442-C730CEFB-F3FD-41FB-B347-53E7076C03C0

Q28141442-C9EE4E81-FCED-43C6-9222-34202B601990

Q28141442-DE22B3D1-3446-45F2-B479-6879C4FFDA18

Q28141442-E565665E-2907-4AAF-B0CF-9AFBE97B91BF

Q28141442-E680DC27-58F3-46A6-A0F9-B53EBAF347D0

Q28141442-EE216D51-8361-45C7-B9F5-FE4C4F84CC4B

P304

Q28141442-71429CB7-92AF-4342-BFCE-1E82EBDF7C63

P31

Q28141442-1DF2CDEF-78F3-4571-B124-8C480199F370

P3181

Q28141442-661B4C33-C0A4-4CEF-92C5-EC9EC59BE3FE

P356

Q28141442-C81D2C95-F358-4932-AAB7-6621B6971456

P407

Q28141442-8270A036-C601-4CA0-8953-9A414B0059D8

P433

Q28141442-0601A884-2A56-4E3C-BEC0-067FC3E9E31C

P478

Q28141442-2981C278-DE0A-4625-B70C-51A4D44551DA

P577

Q28141442-6EAC24E9-DEEE-43CE-84A9-8E3F3FD01D89

P698

Q28141442-C8563AFF-50DD-4B47-B775-406F6CE84C3D

P921

Q28141442-39B88B74-0D5F-434F-81BC-731024F0206A

Q28141442-D539CCF4-8686-4C69-B4E3-50560F9908AA

P3181

P356

NEJM200012283432602

P1433

The New England Journal of Medicine

P1476

Genomic aberrations and survival in chronic lymphocytic leukemia

@en

P2093

A Benner

http://www.w3.org/2001/XMLSchema#string

A Kröber

http://www.w3.org/2001/XMLSchema#string

E Leupolt

http://www.w3.org/2001/XMLSchema#string

H Döhner

http://www.w3.org/2001/XMLSchema#string

K Döhner

http://www.w3.org/2001/XMLSchema#string

L Bullinger

http://www.w3.org/2001/XMLSchema#string

M Bentz

http://www.w3.org/2001/XMLSchema#string

P Lichter

http://www.w3.org/2001/XMLSchema#string

S Stilgenbauer

http://www.w3.org/2001/XMLSchema#string

P304

1910-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1634966

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM200012283432602

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

343

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11136261

http://www.w3.org/2001/XMLSchema#string

P921